Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 37 recruiting now later-stage tilt #66 of 28,707 conditions

Bipolar Disorder: later-stage trial registry

37 of 163 indexed Bipolar Disorder trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #66 of 28,707 conditions by registered trial count.

163 US clinical trials · 37 currently recruiting · #66 of 28,707 conditions by registered trial count

Bipolar Disorder: 163 US clinical trials tracked, 37 recruiting.

Bipolar Disorder is the subject of 163 registered US clinical trials on ClinicalTrials.gov, 37 of them currently open to new participants. 45 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 11 of these trials.

Enrollment posture brief

Registry condition bipolar-disorder

OPEN 37 | RECR 23% | LATE 45 | EARLY 15 | RANK #66 | SPON 11

Nearest open-share peer: Hypogonadism (23% recruiting · 22 trials)

Epilepsy47.6%Gastric Cancer45.3%Neoplasms31.3%Parkinson's Disease26.1%Bipolar Disorder (this)23%
Open-enrollment share among volume-matched conditions near Bipolar Disorder

Bipolar Disorder lists 37 open slots (23% of 163 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bipolar Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bipolar Disorder is recruiting below its size-band peers.

    37 of 163 indexed trials (22.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Bipolar Disorder trials is spread across many organizations.

    Massachusetts General Hospital accounts for 11 of 163 trials (6.7%). 73 distinct sponsors appear on at least one study for this condition label.

  3. Typical Bipolar Disorder enrolment sits around 75 participants.

    Median target enrolment is 75 among the 163 trials that report a genuine target (sentinel values excluded). 92 of those (56.4%) plan for fewer than 100 participants.

  4. Bipolar Disorder research is mostly interventional.

    133 interventional and 30 observational studies make up this index (81.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 212Phase 323Phase 422

Open and recent trials

163 total, page 4 of 4

COMPLETED Phase 4 25 participants

Geodon in Weight Loss Study for Bipolar Disorders

Stanford University

NCT00472641

COMPLETED NA 25 participants

Financial Incentives to Improve Medication Adherence

Northwell Health

NCT04191876

COMPLETED Phase 4 24 participants

Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation

Boston Medical Center

NCT02845453

COMPLETED NA 23 participants

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

Stanford University

NCT03935854

COMPLETED NA 23 participants

A Trial of SAMe for Treatment-Resistant Bipolar Depression

Mclean Hospital

NCT00762268

COMPLETED Phase 4 20 participants

Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

Massachusetts General Hospital

NCT00181922

COMPLETED 20 participants

Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients

Case Western Reserve University

NCT00763581

COMPLETED Phase 1 20 participants

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

Otsuka Pharmaceutical Development & Commercialization

NCT00321516

COMPLETED NA 19 participants

Brain Stimulation and Cognitive Training - Efficacy

University of Michigan

NCT05111548

COMPLETED Phase 2 19 participants

Effects of Pentazocine Versus Lorazepam on Manic Symptoms

Mclean Hospital

NCT00431184

COMPLETED NA 13 participants

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

New York State Psychiatric Institute

NCT04244786

COMPLETED 10 participants

Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?

Northwestern University

NCT01784341

COMPLETED NA 7 participants

Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolar Disorder

New York State Psychiatric Institute

NCT00338806

← Previous Page 4 of 4

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 12
Phase 3 23
Phase 4 22

Named interventions

Most-linked intervention names on Bipolar Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
19 trials
Lithium Drug
9 trials
Quetiapine Drug
4 trials
Aripiprazole Drug
3 trials
Valproate Drug
3 trials
Lamotrigine Drug
3 trials
Placebo Other
3 trials
paroxetine Drug
2 trials

US sites by state

Facility locations filed on Bipolar Disorder trials. A trial with sites in several states counts in each.

California 35 trials
Massachusetts 32 trials
Texas 26 trials
New York 24 trials
Ohio 23 trials
Maryland 18 trials
Florida 18 trials
Pennsylvania 17 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Bipolar Disorder page

163 registered trials, 37 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bipolar Disorder condition card totals 163 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.